Type / Class
Equity / Class A Common Stock, par value $0.0001 per share
Shares outstanding
126M
Number of holders
110
Total 13F shares, excl. options
63.5M
Shares change
+572K
Total reported value, excl. options
$182M
Value change
+$1.72M
Number of buys
52
Number of sells
-52
Price
$2.86

Significant Holders of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) as of Q3 2024

128 filings reported holding ORGO - Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share as of Q3 2024.
Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) has 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 63.5M shares of 126M outstanding shares and own 50.3% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (12M shares), Soleus Capital Management, L.P. (11.8M shares), BlackRock, Inc. (5.33M shares), DEUTSCHE BANK AG\ (4.84M shares), VANGUARD GROUP INC (3.67M shares), ACADIAN ASSET MANAGEMENT LLC (3.02M shares), AQR CAPITAL MANAGEMENT LLC (2.71M shares), DIMENSIONAL FUND ADVISORS LP (2.35M shares), Assenagon Asset Management S.A. (1.92M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.75M shares).
This table shows the top 110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.